Clinic for Treating Muscle Loss in COPD Patients
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
Recruiting
N/A
Interventional Study
COPD
Emphysema
Sarcopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- The Cleveland Clinic · Other
Who this trial is looking for
This trial is looking for patients with COPD who have muscle loss. Participants will receive specialized care from a team of healthcare professionals to help improve their muscle strength and overall health.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a COPD exacerbation that caused my hospital stay.
- I am over 40 years old.
- I have CT imaging showing low muscle mass in my chest.
- I have been diagnosed with COPD that includes moderate obstruction.
- I have smoked at least 10 pack years.
You may not be able to join if
- I have a history of other serious lung diseases like asthma.
- I am currently being evaluated for a lung transplant.
- I have an active cancer.
- I have severe heart failure or kidney disease requiring dialysis.
- I have liver disease shown by imaging.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Sarcopenia, or skeletal muscle loss, impacts up to 40% of COPD patients and is a major cause for morbidity and mortality. Despite the high clinical significance of sarcopenia in COPD, the diagnosis remains elusive because accurate measures of skeletal muscle are not tested during routine clinical care. The goal is to use evidence-based strategies to diagnose and treat sarcopenia due to COPD. The m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. COPD exacerbation as the primary cause for inpatient hospitalization OR secondary diagnosis of COPD exacerbation with acute respiratory failure as the primary diagnosis.
2. Patients must have CT (Computed Tomography) imaging performed during their admission and evidence of lo…
Contacts